Medically reviewed by Dr. Pedro Loredo, MD · Last reviewed: 2026-04-27

A cortisone injection in the thumb CMC joint can feel like a small miracle the first time. Pain that defined daily life for months disappears within days. The problem is that the relief does not last forever, and most patients eventually find that the next injection works less well, then the one after that, and then they are wondering what to do next. This article explains the lifecycle of cortisone injections in thumb basilar joint arthritis, why repeat injections become less effective over time, and how to know when to escalate to surgical reconstruction.

The Cortisone Injection Lifecycle

The thumb CMC joint is a saddle-shaped articulation at the base of the thumb. As cartilage wears with age and use, the joint becomes painful, particularly with pinching, gripping, and twisting motions. Cortisone injection reduces inflammation in the synovium and capsule of the joint, providing meaningful pain relief.

The first injection in early-to-moderate disease often lasts 6 to 12 months. The thumb feels almost normal during that period. Patients return to opening jars, turning keys, and using tools without thinking about the joint. When the injection wears off, pain returns, often gradually at first, then more decisively.

The second injection in the same joint typically lasts 4 to 6 months. The third often only 2 to 3 months. The shrinking duration reflects ongoing cartilage wear underneath the inflammation. Cortisone reduces the inflammatory response but does not regrow the cartilage. As the joint surface continues to deteriorate, the proportion of pain that comes from mechanical bone-on-bone contact (which cortisone does not address) grows relative to the inflammatory component.

A short post from Dr. Loredo on thumb base arthritis. View on Instagram.

How Many Injections Is Too Many?

Most hand surgeons cap thumb CMC cortisone at 2 to 4 lifetime injections in the same joint, spaced 3 to 4 months apart at minimum. Repeat injections beyond that produce diminishing relief and increase a few risks: cartilage softening, joint capsule weakening, and a small infection risk per injection.

The exact cap depends on the patient. A 75-year-old with moderate arthritis who got 12 months from the first injection and 8 months from the second is reasonable to consider for a third before surgery. A 55-year-old with severe arthritis whose third injection produced only 6 weeks of relief is better served by reconstruction at this point. The decision is shared, based on the response trajectory and the patient's life situation.

What Surgery Offers

Thumb CMC reconstruction (basilar joint arthroplasty) addresses the mechanical problem rather than the inflammatory one. The arthritic trapezium is removed, eliminating the bone-on-bone contact that produces pain. The thumb metacarpal is then stabilized in its anatomic position using one of several techniques: ligament reconstruction tendon interposition (LRTI) using the FCR tendon, suture suspension arthroplasty, or pyrocarbon implant.

Outcomes are excellent. Long-term studies of LRTI show 90 percent or higher patient satisfaction at 10 to 20 years. The pain that defined daily life before surgery is gone. Strength returns to 80 to 90 percent of an unaffected contralateral thumb. Most patients describe the result as life-changing.

The trade-off is recovery time. CMC reconstruction is a major operation: 4 to 6 weeks in a thumb spica splint, 6 to 12 weeks of structured hand therapy, and 3 to 6 months to full strength. Patients who have run out of injection options and are limited by pain typically find this trade worth it. See our CMC reconstruction page for the full procedure detail and our CMC arthroplasty recovery guide for what to expect after.

Realistic Expectations

The decision to move from injections to surgery is not just about the joint. It is also about how thumb pain is affecting your life. Patients who say "I cannot open my pill bottles," "I dropped a glass at work last week," or "I cannot hold my granddaughter" are usually ready. Patients whose pain is intermittent and manageable with occasional NSAIDs and an injection every year or two are reasonable to keep in the conservative pathway.

Surgery does not produce a normal thumb. The trapezium has been removed, and the thumb metacarpal sits in a slightly different position than its native anatomy. Strength may end up at 80 to 90 percent of an unaffected contralateral thumb. The functional outcome is what matters: opening jars, turning keys, gripping tools, and using the thumb for daily tasks all return.

Who Is Not a Surgical Candidate?

Surgery is not the right answer for every patient. Reasonable candidates for ongoing conservative care include:

  • Patients with mild symptoms managed by occasional NSAIDs, a thumb spica splint during aggravating activities, and infrequent injections
  • Patients with significant medical comorbidities that increase surgical risk
  • Patients with active infection or unhealed wounds in the operative area
  • Patients who are not ready for the 4 to 6 week splint phase and the 3 to 6 month total recovery
  • Patients whose injections are still providing 6 or more months of relief and who are not significantly limited by pain

The decision is shared between the patient and the surgeon, based on the response to conservative care, the imaging findings, and the patient's life context.

Why Waiting Too Long Has a Cost

There is no medical advantage to delaying surgery once injections have failed. Patients who wait many years often develop secondary changes: a thumb metacarpal that has shifted into a fixed adducted position, intrinsic muscle tightening, and stiffness in the IP joint. The reconstruction itself remains possible, but the recovery may be slower and the final result somewhat less complete than for patients who proceeded earlier.

Anxiety about surgery is understandable. Most patients who delay do so out of hope that injections will keep working or fear of the recovery. The most common comment we hear after CMC reconstruction is "I should have done this earlier." That is the practical answer to the question of when to escalate from injections to surgery: when injections are no longer providing adequate relief and pain is limiting your daily life, surgery is the better path.

Frequently Asked Questions

How long does a thumb CMC injection usually last?

The first cortisone injection often lasts 6 to 12 months in early-to-moderate thumb CMC arthritis. Subsequent injections in the same joint typically produce shorter intervals of relief: a second might last 4 to 6 months, a third only 2 to 3 months. The shrinking duration reflects ongoing cartilage wear, not a problem with the injection technique. When the duration of relief drops below several months, surgery is often the better next step.

Can I keep getting injections forever?

No. Most hand surgeons cap thumb CMC injections at 2 to 4 lifetime injections in the same joint, spaced no closer than 3 to 4 months apart. Repeat injections beyond this point produce diminishing relief and increase the risk of cartilage degradation, joint capsule weakening, and infection. The exact cap depends on the patient's overall health, the response to prior injections, and the imaging findings.

Is surgery only for severe arthritis?

No. CMC reconstruction is appropriate when conservative care has failed and pain is limiting daily life, regardless of the radiographic stage. Some patients with mild radiographic findings have severe pain; some patients with advanced radiographic arthritis have manageable symptoms. The decision is based on functional limitation, not the X-ray alone. Outcomes are excellent across the spectrum when the indication is right.

What if I wait too long?

Waiting too long can produce a thumb metacarpal that has shifted into a fixed adducted position, with secondary stiffness and intrinsic muscle tightening. The reconstruction itself is still possible, but the recovery may be slower and the outcome slightly less complete than for patients who proceed earlier. There is no benefit to waiting once injections no longer provide adequate relief and pain is limiting daily life.

Related Reading

Ready to discuss next steps?

Call Loredo Hand Care Institute. We work through the injection-versus-surgery decision together based on your specific response to conservative care.